General Lab and Labco to create a leading European medical diagnostics Group
With 44 fully-owned laboratories and 27 partnerships with hospitals in Spain and Portugal, General Lab shall enable Labco to further increase its European footprint. After the integration, the Labco network expects to reach sales of c. EUR240 million in 2007, positioning itself as the main independent European player with a significant presence in key markets. As such, Labco is shaping the EUR25 to EUR30 billion laboratory medicine sector in Europe.
General Lab will pursue its independent growth in Iberia, while its managers will be fully integrated into the global governance of the group. The combined management team will be bringing together their specific expertise of operating in two different healthcare systems for the benefit of both Labco and General Lab.
Other news from the department business & finance
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.
Topic world Diagnostics
Diagnostics is at the heart of modern medicine and forms a crucial interface between research and patient care in the biotech and pharmaceutical industries. It not only enables early detection and monitoring of disease, but also plays a central role in individualized medicine by enabling targeted therapies based on an individual's genetic and molecular signature.